PSPrerna Saxena

Prerna Saxena

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Prerna Saxena has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Current Treatment Modalities Associated With Glioblastoma and Its Merits and Demerits

    by Rizwan Ahamad, Nazreen Tabassum, Arshi Aquil, Prerna Saxena, Rabnoor Alam, Suruchi Khanna, Mohd Akhtar, Mohd Aqil, Mohd Mujeeb

    Glioblastoma multiforme (GBM) is an aggressive primary brain tumor marked by rapid progression, diffuse infiltration, and poor prognosis. Conventional treatments—surgical resection, radiotherapy, and temozolomide chemotherapy—offer limited success due to intratumoral heterogeneity, the blood-brain barrier (BBB), glioma stem-like cells. Novel immunotherapeutic strategies, including immune checkpoint inhibitors, CAR T and CAR-NK cells, dendritic cell vaccines, and oncolytic virotherapy, are under investigation to improve immune-mediated tumor eradication. Tumor-treating fields (TTFs) and targeted molecular therapies show additional promise. This chapter explores the molecular and metabolic landscape of GBM, reviews current and emerging therapies, and underscores the urgent need for integrated, personalized treatment strategies to improve patient outcomes.